Suppr超能文献

人血浆蛋白与金黄色葡萄球菌细胞壁成分之间的相互作用。

Interactions between human plasma proteins and cell wall components of Staphylococcus aureus.

作者信息

Espersen F

出版信息

Dan Med Bull. 1987 Apr;34(2):59-69.

PMID:3556046
Abstract

Staphylococcus aureus has surface structures with affinity to human IgG, fibrinogen, and fibronectin. Besides the binding of the Fc-terminal part of IgG from a range of mammalian species, S. aureus protein A binds some IgM, IgA, and IgE molecules. Furthermore, it seems also able to bind immunoglobulins via their Fab-terminal parts. Protein A (Mr 42,000) is the only well-characterized S. aureus cell wall protein, and its structure is known in detail. A considerable number of biological properties of protein A has been demonstrated. Most of these properties seem to be a consequence of the complement activation induced by protein A-IgG complexes. The role of protein A in the phagocytosis of S. aureus is complex. By complement consumption protein A has been found to inhibit the phagocytosis of staphylococci by polymorphonuclear leucocytes. However, it has been demonstrated that protein A-containing staphylococci bind to surface IgG on human alveolar and peritoneal macrophages and thereby promote phagocytosis by these cells. This phenomenon might explain the increased virulence of S. aureus in the presence of human IgG in experimental peritonitis in mice. Fibrinogen binds to a surface structure on S. aureus, designated clumping factor as the binding results in clumping of whole bacteria. Recently, a glycoprotein (Mr of about 400,000) has been isolated from S. aureus. This glycoprotein seems to be the clumping factor. It binds to fibrinogen, inhibits the fibrinogen induced clumping, and seems to be a S. aureus specific, surface component. The isolated component activates human complement in vitro. Also, it induces protection against S. aureus peritonitis in immunized mice. The presence of fibrinogen and an unknown human plasma component increases the virulence of S. aureus in experimental peritonitis in mice, but the role of fibrinogen in human S. aureus infection is unknown. Fibronectin binds to a surface protein on S. aureus, and this binding also results in the clumping of the bacteria. The binding site(s) for fibronectin is different from the binding sites for fibrinogen and IgG. A fibronectin-binding protein (Mr 197,000) has been isolated from S. aureus by affinity chromatography. This protein binds fibronectin and inhibits the fibronectin induced S. aureus clumping. No other biological properties of this protein have yet been demonstrated. The binding of fibronectin to S. aureus opsonize the bacteria for polymorphonuclear leucocytes. The opsonic capacity is, however, low compared to other serum opsonins. It has been suggested that fibronectin plays a role in the attachment of S. aureus, but further studies are needed.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

金黄色葡萄球菌具有与人类免疫球蛋白G(IgG)、纤维蛋白原和纤连蛋白具有亲和力的表面结构。除了能结合多种哺乳动物物种IgG的Fc末端部分外,金黄色葡萄球菌蛋白A还能结合一些IgM、IgA和IgE分子。此外,它似乎还能通过其Fab末端部分结合免疫球蛋白。蛋白A(分子量42,000)是唯一一种特征明确的金黄色葡萄球菌细胞壁蛋白,其结构已被详细了解。已证实蛋白A具有相当多的生物学特性。这些特性中的大多数似乎是由蛋白A-IgG复合物诱导的补体激活所导致的。蛋白A在金黄色葡萄球菌吞噬作用中的作用很复杂。通过消耗补体,发现蛋白A可抑制多形核白细胞对葡萄球菌的吞噬作用。然而,已证明含有蛋白A的葡萄球菌能与人肺泡和腹腔巨噬细胞表面的IgG结合,从而促进这些细胞的吞噬作用。这种现象可能解释了在小鼠实验性腹膜炎中,当存在人类IgG时金黄色葡萄球菌毒力增加的原因。纤维蛋白原与金黄色葡萄球菌的一种表面结构结合,这种结合导致全菌聚集,该表面结构被称为聚集因子。最近,从金黄色葡萄球菌中分离出一种糖蛋白(分子量约400,000)。这种糖蛋白似乎就是聚集因子。它能结合纤维蛋白原,抑制纤维蛋白原诱导的聚集,似乎是金黄色葡萄球菌特有的表面成分。分离出的这种成分在体外可激活人类补体。此外,它能在免疫小鼠中诱导对金黄色葡萄球菌腹膜炎的保护作用。纤维蛋白原和一种未知的人类血浆成分的存在会增加小鼠实验性腹膜炎中金黄色葡萄球菌的毒力,但纤维蛋白原在人类金黄色葡萄球菌感染中的作用尚不清楚。纤连蛋白与金黄色葡萄球菌的一种表面蛋白结合,这种结合也会导致细菌聚集。纤连蛋白的结合位点与纤维蛋白原和IgG的结合位点不同。已通过亲和层析从金黄色葡萄球菌中分离出一种纤连蛋白结合蛋白(分子量197,000)。这种蛋白能结合纤连蛋白并抑制纤连蛋白诱导的金黄色葡萄球菌聚集。尚未证明该蛋白具有其他生物学特性。纤连蛋白与金黄色葡萄球菌的结合可使细菌被多形核白细胞调理。然而,与其他血清调理素相比,其调理能力较低。有人认为纤连蛋白在金黄色葡萄球菌的黏附中起作用,但还需要进一步研究。(摘要截短至400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验